Bionano Genomics (BNGO) Non-Current Assets (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Non-Current Assets data on file, last reported at $25.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 22.86% year-over-year to $25.8 million; the trailing twelve-month figure through Mar 2026 stood at $117.6 million (down 34.59% YoY), and the FY2025 full-year result was $28.2 million, down 24.16% from the prior year.
• Non-Current Assets declined to $25.8 million in Q1 2026, from $28.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $150.2 million in Q4 2022 to a low of $25.8 million in Q1 2026.
• A 5-year average of $75.7 million and a median of $72.4 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 624.51% in 2022 and plunged 53.77% in 2024, its largest moves.
• Tracing BNGO's Non-Current Assets over 5 years: stood at $150.2 million in 2022, then plunged by 50.54% to $74.3 million in 2023, then slumped by 49.95% to $37.2 million in 2024, then fell by 24.16% to $28.2 million in 2025, then decreased by 8.4% to $25.8 million in 2026.
• Business Quant data shows BNGO's Non-Current Assets at $25.8 million in Q1 2026, $28.2 million in Q4 2025, and $30.3 million in Q3 2025.